MacroBea
Nanocarrier-based Dermal Delivery Technology
Health Tech & Life Sciences
Non Active, Jan 2020 ceased to operate
Company Overview
Snapshot
Founded in November 2010 by Simon Benita, MacroBea operates with 1–10 employees. The company is in the Pre-Funding stage and ceased operations in January 2020.
Business overview
MacroBea develops a platform technology for the dermal delivery of active ingredients, utilizing novel, tailored biodegradable nanocarriers. This invention, developed by Prof. Simon Benita from the Institute for Drug Research at the Hebrew University in Jerusalem, aims to address versatile and unmet needs in the market. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Cosmetic Materials, serving the Cosmetics and Pharmaceuticals industries.
Log in to access full profile ›Company Intelligence Q&A
- What is MacroBea's primary technology?
- MacroBea's primary technology is a nanocarrier-based dermal delivery system for active ingredients, utilizing novel, tailored biodegradable nanocarriers.
- When was MacroBea founded?
- MacroBea was founded in November 2010.
- Who founded MacroBea?
- MacroBea was founded by Simon Benita.
- In which sector does MacroBea primarily operate?
- MacroBea primarily operates in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Cosmetic Materials.
- What is the current operational status of MacroBea?
- MacroBea is currently non-active, having ceased to operate in January 2020.